Sector:
Healthcare

Location:
Cambridge, MA

Year Funded:
2001

Status:
Acquired by Baxter
International, Inc.

Website:
www.archemix.com

Summary:
Archemix is a biotechnology company focused on discovering, developing and commercializing aptamer therapeutics. Using Archemix’s processes for discovering aptamers, which are protected by its broad patent portfolio, Archemix is developing aptamer product candidates for rare hematological diseases.